321 related articles for article (PubMed ID: 19914029)
1. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
Bretagne JF
Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
[No Abstract] [Full Text] [Related]
2. Clopidogrel with or without omeprazole in coronary disease.
Juurlink DN
N Engl J Med; 2011 Feb; 364(7):681-2; author reply 682-3. PubMed ID: 21323548
[No Abstract] [Full Text] [Related]
3. Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit?
Serebruany V; Goto S
Thromb Haemost; 2009 Apr; 101(4):607-9. PubMed ID: 19350100
[No Abstract] [Full Text] [Related]
4. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
5. [Clinical importance of the clopidogrel - omeprazole interaction: a question to solve].
Amariles P; Holguín H; Ceballos M
Aten Primaria; 2012 Mar; 44(3):e16. PubMed ID: 21885164
[No Abstract] [Full Text] [Related]
6. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
Marcucci R
G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
[No Abstract] [Full Text] [Related]
7. [Dilemma between gastroprotection and cardiovascular prevention].
Venerito M; Kandulski A; Malfertheiner P
Dtsch Med Wochenschr; 2010 Nov; 135(44):2193-8. PubMed ID: 20979006
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel and PPI interaction: clinically relevant or not?
Harrison RW; Mahaffey KW
Curr Cardiol Rep; 2012 Feb; 14(1):49-58. PubMed ID: 22090195
[TBL] [Abstract][Full Text] [Related]
9. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
10. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
Morini S; Zullo A
G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
[No Abstract] [Full Text] [Related]
11. Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding.
Tan HJ; Mahadeva S; Menon J; Ng WK; Zainal Abidin I; Chan FK; Goh KL; ;
J Dig Dis; 2013 Jan; 14(1):1-10. PubMed ID: 23134105
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel with or without omeprazole in coronary artery disease.
Bhatt DL; Cryer BL; Contant CF; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Scirica BM; Murphy SA; Cannon CP;
N Engl J Med; 2010 Nov; 363(20):1909-17. PubMed ID: 20925534
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and clopidogrel.
Gaglia MA; Waksman R
Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
[TBL] [Abstract][Full Text] [Related]
14. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations.
Tantry US; Kereiakes DJ; Gurbel PA
JACC Cardiovasc Interv; 2011 Apr; 4(4):365-80. PubMed ID: 21511216
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
Vaduganathan M; Cannon CP; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Bhatt DL;
Am J Med; 2016 Sep; 129(9):1002-5. PubMed ID: 27143321
[TBL] [Abstract][Full Text] [Related]
17. [Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].
Casado-Arroyo R; Muñoz-Villalenguas M; Lanas Arbeloa A
Gastroenterol Hepatol; 2011; 34(7):478-91. PubMed ID: 21684042
[TBL] [Abstract][Full Text] [Related]
18. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP;
J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors and clopidogrel: is it a significant drug interaction?
Oyetayo OO; Talbert RL
Expert Opin Drug Saf; 2010 Jul; 9(4):593-602. PubMed ID: 20377472
[TBL] [Abstract][Full Text] [Related]
20. Management of patients with high gastrointestinal risk on antiplatelet therapy.
Cryer B
Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
